# Aprea Therapeutics (APRE) — Analyst Forecast

APRE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/apre/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 4 | 0 | 0 | 4 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 14, 2026 | Ladenburg Thalmann | Initiated Coverage | Buy | $2.00 |
| Aug 13, 2026 | Wedbush | Maintained | Outperform | $3.00 |
| May 14, 2026 | Wedbush | Maintained | Outperform | $6.00 |
| May 7, 2026 | Oppenheimer | Initiated Coverage | Outperform | $5.00 |
| Mar 31, 2026 | HC Wainwright & Co. | Maintained | Buy | $1.20 |
| Mar 31, 2026 | Wedbush | Maintained | Outperform | $7.00 |
| Feb 10, 2026 | Wedbush | Maintained | Outperform | $7.00 |
| Jan 29, 2026 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Dec 18, 2025 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Jan 15, 2025 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Dec 17, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Nov 18, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Oct 24, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Aug 13, 2024 | Wedbush | Maintained | Outperform | $11.00 |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Jun 24, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Jun 17, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| May 14, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Mar 27, 2024 | Wedbush | Maintained | Outperform | $11.00 |
| Mar 26, 2024 | HC Wainwright & Co. | Maintained | Buy | $20.00 |

## Frequently Asked Questions

### Is APRE a buy, sell, or hold?

Analysts covering Aprea Therapeutics currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on APRE?

On Oct 14, 2026, Ladenburg Thalmann initiated coverage of Aprea Therapeutics at Buy with a price target of $2.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).